SQZ Biotechnologies Company
SQZ was delisted on the 3rd of July, 2023.
31 hedge funds and large institutions have $2.96M invested in SQZ Biotechnologies Company in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 3 closing their positions.
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
3% less funds holding
Funds holding: 32 → 31 (-1)
53% less capital invested
Capital invested by funds: $6.36M → $2.96M (-$3.4M)
70% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Prudential Financial
Newark,
New Jersey
|
+$22.8K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16.6K |
| 3 |
Renaissance Technologies
New York
|
+$5.28K |
| 4 |
Goldman Sachs
New York
|
+$574 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$367 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$160K |
| 2 |
BlackRock
New York
|
-$33K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$20.2K |
| 4 |
Millennium Management
New York
|
-$14K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$12.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Barclays
London,
United Kingdom
| $484 | – | – | – |
|
27
UBS Group
Zurich,
Switzerland
| $381 | -$689 | -1,214 | -46% |
|
28
Bank of America
Charlotte,
North Carolina
| $342 | -$1.7K | -2,993 | -70% |
|
29
Wells Fargo
San Francisco,
California
| $38 | +$3 | +6 | +4% |
|
|
FDCDDQ
30
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $28 | – | – | – |
|
|
TSS
31
Two Sigma Securities
New York
| – | -$20.2K | -36,069 | Closed |
|
|
VF
32
Virtu Financial
New York
| – | -$10K | -17,075 | Closed |
|
33
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$558 | -1,000 | Closed |
|
|
34
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$367 | +646 | New |
|
SQZ Hedge Fund Activity: Q2 2023 in Review
31 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q2 2023, worth a combined $2.96M — down 53% from $6.36M a quarter earlier.
Fund positioning in SQZ was balanced in Q2 2023: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 10 trimmed.
The largest buyer was Prudential Financial, opening a new position worth an estimated $22.8K. The largest seller was Morgan Stanley, cutting an estimated $160K.
- 31 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q2 2023, down from 32 in Q1 2023.
- Funds reported $2.96M of SQZ Biotechnologies Company stock for Q2 2023, down 53% quarter-over-quarter.
- 3 funds opened new SQZ Biotechnologies Company positions in Q2 2023 and 3 closed out, a net change of 0 holders.
- The largest SQZ Biotechnologies Company buyer in Q2 2023 was Prudential Financial, an estimated $22.8K added.
- The largest SQZ Biotechnologies Company seller in Q2 2023 was Morgan Stanley, an estimated $160K sold.
Based on aggregated 13F filings for Q2 2023.